CN100421703C - Gout granules - Google Patents

Gout granules Download PDF

Info

Publication number
CN100421703C
CN100421703C CNB2006100881033A CN200610088103A CN100421703C CN 100421703 C CN100421703 C CN 100421703C CN B2006100881033 A CNB2006100881033 A CN B2006100881033A CN 200610088103 A CN200610088103 A CN 200610088103A CN 100421703 C CN100421703 C CN 100421703C
Authority
CN
China
Prior art keywords
gout
medicine
rhizoma
treatment
uric acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CNB2006100881033A
Other languages
Chinese (zh)
Other versions
CN1895522A (en
Inventor
朱良春
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CNB2006100881033A priority Critical patent/CN100421703C/en
Publication of CN1895522A publication Critical patent/CN1895522A/en
Application granted granted Critical
Publication of CN100421703C publication Critical patent/CN100421703C/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

A Chinese medicine 'Gout particle' for treating gout is prepared from 7 Chinese-medicinal materials including China root, silkworm excrement, plantain herb, clematis root, etc.

Description

Gout granules
Technical field:
The present invention relates to a kind of medicine for the treatment of gout.
Background technology:
Gout is the disease due to a kind of purine metabolic disturbance.Primary gout arthritis and high protein recipe etc. have substantial connection, and be more rare in China in the past.The European and American countries sickness rate is about 2/1000ths to three, and certain areas are up to 3/1000ths, because nutrition improvement and average life prolong, the gout sickness rate also rises year by year over past ten years in China.(1) (2) primary gout arthritis is improper as preventing and treating, not only acute attack has very big misery, and easily cause serious consequences such as joint deformity, renal calculus, renal function injury, renal insufficiency person prognosis heterodyne, often with obesity, hyperlipidemia, hyperglycemia, hypertension tendency, these also are the precipitating factors that forms diabetes, atherosclerosis, coronary heart disease, renal arteriolosclerosis, cerebral arteriosclerosis to patient with gout.In treatment, Western medicine colchicine pain relieving commonly used so far, allopurinol suppresses uricopoiesis, probenecid increases urate excretion, in taking except that gastrointestinal reaction such as nausea,vomiting,diarrhea occurring, can be to the inhibition of bone marrow, or cause leucocytes reduction, and the infringement of hepatic and renal function.After allopurinol is taken, heating can be arranged, allergic rash, stomachache, diarrhoea.Leukocyte and thrombocytopenia, even liver function injury, the idol dermatitis that necroses, and the outbreak of uric acid transitivity gout can take place during the medication.(2) along with the continuity of medicine time, the patient grows with each passing day to the side effect and the feared state of mind of said medicine, and in 307 routine patient with gout, toxic and side effects person's 62 examples (accounting for 32.98%) take place for clothes allopurinol, colchicine treatment 188 examples according to reports, wherein vomiting, 26 examples of suffering from diarrhoea (accounting for 13.83%); Gastrorrhagia 4 examples (accounting for 2.13%) leukopenia, thrombocytopenia 4 examples (accounting for 2.13%); Bring out heart disease 1 example (accounting for 0.53%); Exfoliative dermatitis 2 examples (accounting for 1.06%), alopecia 2 examples (accounting for 1.06%), dizzy, weak, anasarca 5 examples (accounting for 2.66%); Because of hepatic and renal function injure, exfoliative dermatitis are rescued 4 examples.Account for 2.13%); The patient of 60 routine toxicities all takes medicine by doctor's advice, occurs in 2~3 week backs mostly, and (2) this shows to seek and a kind ofly can drain uric acid to suppress uric acid synthetic, again can reducing swelling and alleviating pain, and the new Chinese patent medicine of safe without toxic side effect, imperative.
Summary of the invention:
The object of the present invention is to provide a kind of effective gout granules of gout for the treatment of.
Technical solution of the present invention is:
A kind of gout granules is characterized in that: the raw material by following weight portion is made:
Rhizoma Smilacis Glabrae 12~25% Bombyx mori L.s 15~20%
Radix Clematidis 15~20% Rhizoma Dioscoreae Hypoglaucaes 12~20%
Rhizoma Paridis 6~20% Radix Cynanchi Paniculatis 8~20%
Semen Plantaginis 4~8%.
It is effective that the present invention treats gout, and clinical trial proves to have the obvious treatment effect, and have no side effect.Show through animal experiment, behind the rat paw subcutaneous injection uric acid sodium turbid solution, the very fast hyperemia in the visible part of naked eyes reddens, but swelling is not fairly obvious in one hour, the swelling of foot sole of the foot portion peaked about the injection back in 4~6 hours, disappearing of the pedal swelling of administration (the present invention) group rat is obviously fast than model group (not giving any medicine), and compares with the colchicine group, and each dosage group of ventilation electuary is also all not inferior aspect detumescence.Clinical treatment shows that 47% patient was difficult for outbreak in 2~5 years.
Model case:
Medical record one: the king * *, man, 48 years old, people from Nantong City.
Suffer from gout and watch year, because work relationship is often treated blood uric acid 672umol/L with courtesy, blood fat: triglyceride 5.6mmol/L, two whole female toes, the frequent repeatability congestion and swelling pain of knee joint, introduce diagnosis and treatment through friend, body is plump, yellow, thin and slightly greasy fur, the matter purple, soft pulse, this is a turbid damp stasis of blood resistance passages through which vital energy circulates, numbness is closed unfavorable, control and to let out turbid blood stasis dispelling, the tonneau passages through which vital energy circulates.
From taking this medicine, after January, arthralgia is shown effect repeatedly and is occurred, continue after ask someone again to buy, take March altogether, blood uric acid, triglyceride are all reduced to normally during health check-up, very happiness.
Follow up a case by regular visits to after 1 year, be careful in one's diet at ordinary times, have and take this medicine 2 bags (every bag 10 grams) after the dinner party, gout is outbreak always.
(this routine patient is that gout merges hyperlipidemia and since used let out this medicine of turbid blood stasis dispelling after, not only uric acid is had Excretion, and triglyceride is also had the ester of falling effect.)
Case two: Lee *, woman, 53 years old, people from Suzhou City.
Suffered from gouty arthritis 10 years, and took probenecid, allopurinol treatment for a long time, because of the anaphylaxis drug withdrawal.With colchicine, slow its hardship of narcaricin, blood uric acid fluctuates about 250umol/L always since nearly 1 year.Leave hospital pain relief after because of gout, arthralgia hospitalization this year, and still two fingers, the palm, buccal, auricle have the gout calculus, arthralgia swelling, dysstasia is obeyed 3 of colchicines every day, indigestion and loss of appetite, anorexia, diarrhoea, xerostomia and hardship, long-term oral ulcer, thick, yellow and greasy fur, thready pulse moistens, and this is the time of turbid arthralgia due to blood stasis, and taste are impaired, control and should let out turbid blood stasis dispelling, spleen invigorating helps fortune.
Two finger-joint rednesses disappear after taking this medicine, and knee joint can be squatted down.Only spiritlessness and weakness, indigestion and loss of appetite, xerostomia and hardship, oral ulcer.Thick fur is yellow greasy, and matter is pale purple, and thready pulse moistens, and continues and goes on it by former method.
Can participate in expedition, free movement of the bowels after several months.Only xerostomia and hardship, oral ulcer.Tongue is greasy in vain, thready pulse moistens, continuously go on it by former method.Ear corridor calculus disappears behind the medicine, very happiness, and spirit is clearly better, and Na Gu is also fragrant, can orthobiosis, white and thin fur is greasy, and the little string of thready pulse is continuously consolidated it by former method.This medicine bag every days 2 (every bag 10 grams) adheres to taking.
Follow up a case by regular visits to: this medicine adheres to that always every days 2, bag was taken, and gout remains dormant so far, and blood uric acid is normal.
The invention will be further described below in conjunction with embodiment.
The specific embodiment:
Embodiment 1:
(1) Rhizoma Smilacis Glabrae 12%, Bombyx mori L. 20%, Radix Clematidis 20%, Rhizoma Dioscoreae Hypoglaucae 18%, Rhizoma Paridis 6%, Radix Cynanchi Paniculati 20%, Semen Plantaginis 4% weight portion are decocted with water, filter, filtrate is condensed into clear paste;
(2) clear paste is made granule by making particulate conventional method.(can be by clear paste: dextrin: Icing Sugar=1: 2: 1 weight ratio)
(3) can carry out disinfection, pack by every bag 9 gram.
During use, can take for 3 times on the one by each 1~2 bag.
Embodiment 2:
The amount ratio of each component (weight) is:
Rhizoma Smilacis Glabrae 19%, Bombyx mori L. 18%, Radix Clematidis 18%, Rhizoma Dioscoreae Hypoglaucae 12%, Rhizoma Paridis 20%, Radix Cynanchi Paniculati 8%, Semen Plantaginis 5% weight portion.All the other are with embodiment 1.
Embodiment 3:
The amount ratio of each component (weight) is:
Rhizoma Smilacis Glabrae 25%, Bombyx mori L. 15%, Radix Clematidis 15%, Rhizoma Dioscoreae Hypoglaucae 20%, Rhizoma Paridis 12%, Radix Cynanchi Paniculati 9%, Semen Plantaginis 4% weight portion.All the other are with embodiment 1.
Embodiment 4:
The amount ratio of each component (weight) is:
The amount ratio of each component (weight) is:
Rhizoma Smilacis Glabrae 13%, Bombyx mori L. 19%, Radix Clematidis 17%, Rhizoma Dioscoreae Hypoglaucae 17%, Rhizoma Paridis 13%, Radix Cynanchi Paniculati 15%, Semen Plantaginis 6% weight portion.All the other are with embodiment 1.

Claims (1)

1. granule for the treatment of gout is characterized in that: prepare this particulate crude drug and consist of:
Rhizoma Smilacis Glabrae 12~25% Bombyx mori L.s 15~20%
Radix Clematidis 15~20% Rhizoma Dioscoreae Hypoglaucaes 12~20%
Rhizoma Paridis 6~20% Radix Cynanchi Paniculatis 8~20%
Semen Plantaginis 4~8%.
CNB2006100881033A 2006-06-26 2006-06-26 Gout granules Active CN100421703C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB2006100881033A CN100421703C (en) 2006-06-26 2006-06-26 Gout granules

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB2006100881033A CN100421703C (en) 2006-06-26 2006-06-26 Gout granules

Publications (2)

Publication Number Publication Date
CN1895522A CN1895522A (en) 2007-01-17
CN100421703C true CN100421703C (en) 2008-10-01

Family

ID=37608263

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB2006100881033A Active CN100421703C (en) 2006-06-26 2006-06-26 Gout granules

Country Status (1)

Country Link
CN (1) CN100421703C (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101461911B (en) * 2008-12-01 2011-11-02 马献山 Chinese medicine oral capsule for treating gout
CN101884749B (en) * 2010-06-24 2011-09-14 浙江中医药大学 Particle for eliminating turbidity and treating arthralgia
CN102028904A (en) * 2011-01-05 2011-04-27 朱婉华 Application of Xinhuang Pian to preparation of medicaments for treating acute bout of gout
CN102145141A (en) * 2011-04-25 2011-08-10 朱婉华 Application of matching medicament to preparation of medicaments for treating chronic gout with gouty tophus
CN102145142A (en) * 2011-04-25 2011-08-10 朱婉华 Application of preparation for dispelling turbidity and dissipating blood stasis in preparation of medicaments for treating gouty arthritis
CN103705812B (en) * 2014-01-16 2016-05-04 郝应芬 A kind of pharmaceutical composition for the treatment of gout and its production and use
CN105056038A (en) * 2015-09-14 2015-11-18 张军 Traditional Chinese medicine for treating gout
CN108704083A (en) * 2018-07-13 2018-10-26 朱婉华 Application of the gout granules in treating diabetes

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1364608A (en) * 2001-01-10 2002-08-21 覃事平 Powder for curing gout

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1364608A (en) * 2001-01-10 2002-08-21 覃事平 Powder for curing gout

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
中医药治疗痛风的现状与展望. 田泽芬,果永宽,彭丽.中国自然医学杂志,第5卷第2期. 2003
中医药治疗痛风的现状与展望. 田泽芬,果永宽,彭丽.中国自然医学杂志,第5卷第2期. 2003 *
中医药治疗痛风研究概述. 旷惠桃.湖南中医杂志,第21卷第2期. 2005
中医药治疗痛风研究概述. 旷惠桃.湖南中医杂志,第21卷第2期. 2005 *

Also Published As

Publication number Publication date
CN1895522A (en) 2007-01-17

Similar Documents

Publication Publication Date Title
CN100421703C (en) Gout granules
CN102008662B (en) Traditional Chinese medicine composition for treating constipation and preparation method thereof
CN104366636B (en) A kind of Gynura procumbens (Lour.) Merr. compound formulation and preparation method and application
JP2001506589A (en) Pharmaceutical composition for treating diabetes
CN101229300B (en) Chinese traditional medicine preparation for treating bone fracture
CN1305499C (en) Medicine for treating chronic constipation
CN1768844A (en) Gastropathy dedicated Chinese medicine
CN111150799A (en) Composition for preventing and treating hyperuricemia and gout as well as preparation method and application thereof
CN102813783A (en) Pure traditional Chinese medicine capsule for treating gout
CN100368000C (en) Compound fleece-flower root granula for gout
CN101664500A (en) Medicament for rapidly treating urinary retention
CN101480412A (en) Honeybee four-treasure for treating prostatosis
CN114404538A (en) Traditional Chinese medicine composition for treating gouty arthritis and application thereof
CN101229221B (en) Chinese traditional medicine for treating thromboangiitis obliterans and preparing method thereof
CN1167453C (en) Zhiyusan powder for curing hemorrhoid
CN114392331A (en) Preparation containing Agkistrodon for treating gouty arthritis
CN100438887C (en) Chinese traditional medicine for treating orthopaedic diseases and its preparation process
CN114191513B (en) Traditional Chinese medicine composition for treating damp-heat type obesity
CN101380414B (en) Traditional Chinese medicine composition for treating gout and hyperuricemia and preparation method thereof
CN101254268B (en) Chinese medicine for curing coryza
CN104825877A (en) Traditional Chinese medicine for treating liver and gallbladder diseases
CN101195006A (en) Exterior applying medicament for treating toothache due to pathogenic wind-fire
CN101204516B (en) Peroral Chinese traditional medicine for lung-heat enuresis
CN1289122C (en) Medicinal composition for treating psoriasis and preparation method thereof
CN1626176A (en) Medication for treating diabetes

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant